Literature DB >> 2216240

Experimental and clinical studies with radiofrequency-induced thermal endometrial ablation for functional menorrhagia.

J H Phipps1, B V Lewis, M V Prior, T Roberts.   

Abstract

A method of ablating the endometrium has been introduced into clinical practice that uses radiofrequency electromagnetic energy to heat the endometrium, using a probe inserted through the cervix. Preliminary studies suggest that over 80% of patients treated will develop either amenorrhea or a significant reduction in flow. The advantages of radiofrequency endometrial ablation over laser ablation or resection are the avoidance of intravascular fluid absorption, simplicity (no special operative hysteroscopic skills are required), speed of operation, and reduced cost compared with the Nd:YAG laser. In this paper, we describe the experimental studies performed during development of this new technique.

Entities:  

Mesh:

Year:  1990        PMID: 2216240     DOI: 10.1097/00006250-199011000-00032

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  4 in total

1.  Laparoscopic and percutaneous ablative techniques in the treatment of renal cell carcinoma.

Authors:  Kent Perry; Amnon Zisman; Allan J Pantuck; Nicolette Janzen; Peter Schulam; Arie S Belldegrun
Journal:  Rev Urol       Date:  2002

2.  Femur shaft fracture following osteoid osteoma radiofrequency ablation.

Authors:  Elias Mazzawi; Daniela Militianu; Mark Eidelman; Yaniv Keren
Journal:  Clin Cases Miner Bone Metab       Date:  2017-12-27

3.  Combining myoma coagulation with endometrial ablation/resection reduces subsequent surgery rates.

Authors:  H A Goldfarb
Journal:  JSLS       Date:  1999 Oct-Dec       Impact factor: 2.172

Review 4.  Minimally invasive ablative approaches in the treatment of renal cell carcinoma.

Authors:  Nicolette Janzen; Amnon Zisman; Allan J Pantuck; Kent Perry; Peter Schulam; Arie S Belldegrun
Journal:  Curr Urol Rep       Date:  2002-02       Impact factor: 2.862

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.